Moderna, Inc.

BOVESPA:M1RN34 Stock Report

Market Cap: R$96.3b

Moderna Management

Management criteria checks 3/4

Moderna's CEO is Stephane Bancel, appointed in Oct 2011, has a tenure of 13.17 years. total yearly compensation is $17.07M, comprised of 9.2% salary and 90.8% bonuses, including company stock and options. directly owns 5.48% of the company’s shares, worth R$5.28B. The average tenure of the management team and the board of directors is 4.7 years and 10.6 years respectively.

Key information

Stephane Bancel

Chief executive officer

US$17.1m

Total compensation

CEO salary percentage9.2%
CEO tenure13.2yrs
CEO ownership5.5%
Management average tenure4.7yrs
Board average tenure10.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Stephane Bancel's remuneration changed compared to Moderna's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$2b

Jun 30 2024n/an/a

-US$6b

Mar 31 2024n/an/a

-US$6b

Dec 31 2023US$17mUS$2m

-US$5b

Sep 30 2023n/an/a

-US$3b

Jun 30 2023n/an/a

US$1b

Mar 31 2023n/an/a

US$5b

Dec 31 2022US$19mUS$1m

US$8b

Sep 30 2022n/an/a

US$12b

Jun 30 2022n/an/a

US$14b

Mar 31 2022n/an/a

US$15b

Dec 31 2021US$18mUS$990k

US$12b

Sep 30 2021n/an/a

US$7b

Jun 30 2021n/an/a

US$3b

Mar 31 2021n/an/a

US$598m

Dec 31 2020US$13mUS$946k

-US$747m

Sep 30 2020n/an/a

-US$597m

Jun 30 2020n/an/a

-US$488m

Mar 31 2020n/an/a

-US$505m

Dec 31 2019US$9mUS$921k

-US$514m

Sep 30 2019n/an/a

-US$535m

Jun 30 2019n/an/a

-US$499m

Mar 31 2019n/an/a

-US$459m

Dec 31 2018US$59mUS$863k

-US$402m

Sep 30 2018n/an/a

-US$299m

Jun 30 2018n/an/a

-US$280m

Mar 31 2018n/an/a

-US$266m

Dec 31 2017US$7mUS$651k

-US$270m

Compensation vs Market: Stephane's total compensation ($USD17.07M) is above average for companies of similar size in the BR market ($USD5.72M).

Compensation vs Earnings: Stephane's compensation has been consistent with company performance over the past year.

CEO

Stephane Bancel (51 yo)

13.2yrs

Tenure

US$17,068,514

Compensation

Mr. Stephane Bancel serves as Board Director of Indigo Agriculture Inc since 2020. Mr Bancel served as Interim President of Valera LLC. He serves as CEO and Director at Valera LLC.Mr. Bancel serves as a S...

Leadership Team

NamePositionTenureCompensationOwnership
Stephane Bancel
CEO & Director13.2yrsUS$17.07m5.48%
R$ 5.3b
Stephen Hoge
Presidentno dataUS$7.34m0.42%
R$ 400.4m
James Mock
Chief Financial Officer2.3yrsUS$4.32m0.0029%
R$ 2.8m
Shannon Klinger
Chief Legal Officer & Corporate Secretary3.5yrsUS$4.31m0.0053%
R$ 5.1m
Jerh Collins
Chief Technical Operations & Quality Officer1.9yrsno datano data
Lavina Talukdar
Senior VP & Head of Investor Relations5.7yrsno datano data
Colleen Hussey
Senior Director of Corporate Communicationsno datano datano data
Tracey Franklin
Chief People & Digital Technology Officer5.2yrsno datano data
Melanie Ivarsson
Chief Development Officer4.9yrsno datano data
Dave Johnson
Chief Data & AI Officerno datano datano data
Charbel Haber
Senior VP & Head of Global Regulatory Science4.7yrsno datano data
Jacqueline Miller
Chief Medical Officer4.6yrsno datano data

4.7yrs

Average Tenure

49.5yo

Average Age

Experienced Management: M1RN34's management team is considered experienced (4.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Stephane Bancel
CEO & Director13.8yrsUS$17.07m5.48%
R$ 5.3b
Noubar Afeyan
Co-Founder14.9yrsUS$663.52k0.58%
R$ 556.6m
Elizabeth Tallett
Independent Director4.4yrsUS$481.27k0.00018%
R$ 173.4k
Robert S. Langer
Member of Scientific Advisory Boardno dataUS$461.27k2.99%
R$ 2.9b
Scott Canute
Member of Technology Advisory Board10.6yrsno datano data
Elizabeth Nabel
Independent Director3.8yrsUS$476.25k0.00055%
R$ 529.7k
Fred Regnier
Member of Technology Advisory Board10.6yrsno datano data
Francois Nader
Independent Non Executive Director5yrsUS$481.27k0.0054%
R$ 5.2m
James Swartz
Member of Technology Advisory Board10.6yrsno datano data
Ulrich von Andrian-Werburg
Member of Scientific Advisory Boardno datano datano data
Jack Szostak
Chairman of Scientific Advisory Board10.6yrsno datano data
John Aunins
Member of Technology Advisory Board10.6yrsno datano data

10.6yrs

Average Tenure

65yo

Average Age

Experienced Board: M1RN34's board of directors are seasoned and experienced ( 10.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 00:47
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Moderna, Inc. is covered by 42 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Ishan MajumdarBaptista Research
Huidong WangBarclays